Cormorant Global Healthcare Master Fund, LP, 10% Owner at OnKure Therapeutics, Inc. (OKUR), sold 24,300 shares at $1.99 ($48K) on 2025-05-12, disclosed to the SEC on 2025-05-14.
Open-market sale of $48k OKUR by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| CRBP | BUY | 2024-09-24 | $14.0M | — | Filing → |
| EYPT | BUY | 2024-04-22 | $21.0M | — | Filing → |
| IMRX | SELL | 2024-03-18 | $4.6M | — | Filing → |